Category: Life Sciences

Place: SUD, Burgweg 7, 4058 Basel

event Life Sciences


Aiming for novel antibiotic approaches: Challenges, new technologies and potential collaborations

The world is running out of useful antibiotics. Over the past decades, pan-resistant strains of major bacterial pathogens have emerged that have rendered clinically available antibiotics ineffective. As a consequence, many of the major achievements of modern medicine are now at risk. With the pipeline of new antimicrobials slowing to a standstill, alternative strategies are required to identify clinically useful antimicrobials.
In Switzerland and the Basel Area in particular, world-leading scientists work in the life sciences, with important industrial companies at the cutting-edge of antibiotic R&D. Our symposium and networking event aims to promote the full potential of synergies between different stakeholders and to increase collaboration between experts in different research-fields who might be able to contribute to antibiotics R&D. The symposium will highlight technologies and approaches that are presently underexploited but that could prove crucial in supporting antibiotic research, ranging from single-cell analysis to exploration of microbial behavior within tissue sites.
The aim of this event is to connect key players in antibiotic-research to discuss present roadblocks to understanding antibiotic action, discovery and development, as well as to discuss how new technologies could help to overcome some of the challenges in the field.
Who should attend?
The symposium aims at an interdisciplinary audience working on antibiotics R&D in industry or academia, as well as at anyone interested in contributing to the field, including biologists, biomedical engineers, chemists and clinicians.
Please join us at this event on April 26th 2018, 17:00 to 19:30, at SUD, Burgweg 7, 4058 Basel.


Door opening


Christoph Dehio, University of Basel and President NRP 72 "Antimicrobial Resistance"

Ralf Dümpelmann,
Markus Seeger, University of Zürich


"Targeting pathogens under patient-like conditions: a Swiss network"

Prof. Dirk Bumann, Biozentrum, University of Basel


«Aiming for novel antibiotic approaches: insights and challenges in antibiotic R&D from an startup perspective”

Dr. Marc Gitzinger, CEO BioVersys


“Microfludics – a promising technology for combating antimicrobial resistance”

Prof. Petra Dittrich,  Department of Biosystems Science and Engineering (BSSE) at ETH in Basel)


“Roche in Antibiotics: The importance of innovation and joint action”

Dr. Ken Bradley, Head of Antibiotics Discovery at Roche Pharmaceutical Research and Early Development (pRED), F. Hoffmann-La Roche A

19:10 Apéro and Networking

Participation to the event is free of charge; however, your registration until April 23th is mandatory.

Cookies uses cookies to ensure you get the best service on our website.
By continuing to browse the site, you are agreeing to the use of cookies.